Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1931 | IKK16 | 2.0 | uM | 1 | MIF | 18.0 | 52 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 1 | MIF | 21.0 | 63 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | MIF | 20.0 | 51 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 1 | MIF | 27.0 | 41 | ||||
RA1869 | 1 | MIF | 22.0 | 38 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 1 | MIF | 23.5 | 30 | ||||
N2759 | 1 | MIF | 18.0 | 43 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 1 | MIF | 26.0 | 33 | ||||
RA1931 | 1 | MIF | 23.0 | 43 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 1 | MIF | 23.0 | 38 | ||||
N2586 | 1 | MIF | 23.0 | 50 | |||||||
0 | MIF | 18.0 | 42 | ||||||||
0 | MIF | 16.0 | 53 | ||||||||
0 | MIF | 17.0 | 62 | ||||||||
0 | MIF | 18.0 | 40 | ||||||||
0 | MIF | 15.5 | 32 | ||||||||
0 | MIF | 14.0 | 26 | ||||||||
RA2159 | 2 | MIF | 39.0 | 64 | |||||||
N2645 | 2 | MIF | 32.5 | 58 | |||||||
RA2708 | 2 | MIF | 24.0 | 45 | |||||||
RA2159 | JNK-IN-8 | 3.0 | uM | 2 | MIF | 33.0 | 54 | ||||
RA2159 | PH-797804 | 0.6 | uM | 2 | MIF | 34.0 | 68 | ||||
N2645 | JNK-IN-8 | 3.0 | uM | 2 | MIF | 25.0 | 49 | ||||
N2645 | PH-797804 | 0.6 | uM | 2 | MIF | 32.5 | 46 | ||||
RA2708 | JNK-IN-8 | 3.0 | uM | 2 | MIF | 32.0 | 51 |